LFCR DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lifecore Biomedical, Inc. securities between October 7, 2020, and March 19, 2024, of the September 27, 2024, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Lifecore securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the firm directly [3]. - The lawsuit alleges that Lifecore made false and misleading statements regarding its financial reporting and internal controls, which led to inaccurate financial statements that would need to be restated [5]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 for the number of settlements in 2017 and recovering over $438 million for investors in 2019 [4]. Group 3: Case Status - No class has been certified yet, meaning investors are not represented by counsel unless they retain one, and they can choose to remain absent from the class [6].